on 28 May 2024
Last Applicant/ Owned by
Nada-ku 657-0013 Kobe-shi Hyogo 657-0013
JP
Serial Number
79372347 filed on 31st Mar 2023
Registration Number
7394363 registered on 28th May 2024
Correspondent Address
Livio RAISON SHI NAGAWA TOGOSHI 403,
TOKYO 142-0052,
JAPAN
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Research and development relating to DNA synthesis technology; technical advisory services relating to DNA synthesis technology; research and development relating to production and analysis of virus vector; technological advisory services relating to production and analysis of virus vector; research and development relating to production and analysis of mRNA; technological advisory services relati Read More
Research and development relating to DNA synthesis technology; technical advisory services relating to DNA synthesis technology; research and development relating to production and analysis of virus vector; technological advisory services relating to production and analysis of virus vector; research and development relating to production and analysis of mRNA; technological advisory services relating to production and analysis of mRNA; research and development relating to gene therapy; technical advisory services relating to gene therapy research; technological advisory services relating to productization of gene therapy products; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, and technical advisory services relating thereto in the fields of protein, antibody, vaccine, virus, virus vector, mRNA, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; technical advisory services relating to genome synthesis technology; research and development, and technical advisory services relating thereto in the fields of protein, vaccine, virus, virus vector, mRNA, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection, and research of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; technical advisory services relating to development of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; quality testing, inspection, and research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; research and development relating to production and analysis of virus vector for others; research and development relating to gene therapy products for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; quality testing, inspection, and research in the fields of agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; research and development in the field of gene expression systems; research and development in the fields of microorganisms and cells; research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; bacteriological research; biological research
N/A
N/A
No 79372347
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
27th Jun 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
28th May 2024 | REGISTERED-PRINCIPAL REGISTER |
12th Mar 2024 | NOTIFICATION PROCESSED BY IB |
12th Mar 2024 | PUBLISHED FOR OPPOSITION |
21st Feb 2024 | NOTICE OF PUBLICATION |
21st Feb 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
21st Feb 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
01st Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
27th Dec 2023 | ASSIGNED TO EXAMINER |
27th Jun 2023 | APPLICATION FILING RECEIPT MAILED |